Newsroom
For media inquiries, please contact 340B Health Senior VP of Communications Richard Sorian at richard.sorian@340bhealth.org or 202-536-2285.
-
DIABETES DRUGS HEAVILY IMPACTED BY DRUGMAKERS’ 340B POLICIES
-
STATEMENT ON MERCK CUTTING OFF 340B DISCOUNTS THROUGH COMMUNITY-BASED PHARMACIES
-
STATEMENT ON HOUSE LANGUAGE IN SUPPORT OF ENDING DRUG COMPANY ATTACKS ON 340B
-
STATEMENT ON PROPOSED MEDICARE PAYMENT CUTS TO 340B HOSPITALS IN 2022
-
STATEMENT ON THE BIPARTISAN PROTECT 340B ACT TO STOP DISCRIMINATORY ACTIONS BY PBMS AND INSURERS
-
340B HEALTH CALLS ON BOEHRINGER INGELHEIM TO WITHDRAW THREAT TO DENY DRUG DISCOUNTS TO SAFETY-NET HOSPITALS
-
STATEMENT ON U.S. SUPREME COURT ORDER IN 340B MEDICARE CUTS LAWSUIT
-
STATEMENT ON WITHDRAWAL OF HHS ADVISORY OPINION ON 340B COMMUNITY PHARMACIES
-
340B HOSPITAL PATIENTS WITH CHRONIC CONDITIONS ARE MORE LIKELY TO BE BLACK, LIVE WITH DISABILITIES, OR HAVE LOW INCOMES
-
JOINT STATEMENT ON THE ANNIVERSARY OF GEORGE FLOYD’S DEATH
-
340B HEALTH BOARD ELECTS TWO NEW MEMBERS
-
STATEMENT ON HRSA ORDERING DRUG COMPANIES TO RESTORE 340B DISCOUNTS ON DRUGS DISPENSED AT COMMUNITY PHARMACIES